Technical Analysis for VRX - Valeant Pharmaceuticals International, Inc.

Grade Last Price % Change Price Change
grade B 16.54 3.44% 0.55
VRX closed up 3.44 percent on Wednesday, November 22, 2017, on 1.62 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical VRX trend table...

Date Alert Name Type % Chg
Nov 20 Stochastic Reached Overbought Other 6.23%
Nov 16 NR7 Range Contraction 15.34%
Nov 16 NR7-2 Range Contraction 15.34%
Nov 16 Narrow Range Bar Range Contraction 15.34%
Nov 15 NR7 Range Contraction 14.46%
Nov 15 1,2,3 Pullback Bullish Bullish Swing Setup 14.46%
Nov 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 14.46%
Nov 15 Calm After Storm Range Contraction 14.46%
Nov 14 Calm After Storm Range Contraction 15.83%
Nov 13 Upper Bollinger Band Walk Other 13.29%

Older signals for VRX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products and medical devices in the areas of neurology, dermatology, and branded generics. It offers dermatology products, such as Zovirax Ointment, Xerese, Retin-A Micro, Elidel, Carac, Acanya gel, Sculptra and Sculptra Aesthetic, Atralin, Solodyn, Zyclara, Ziana, Vanos, Restylane family of products, and Dysport; over-the-counter (OTC) products, including CeraVe and AcneFree; dentistry products, such as Arestin and Teeth Whitening System; ophthalmology products, including Timoptic, Timoptic, Macugen, and Visudyne; and neurology and other products, such as Wellbutrin XL and Xenazine in the United States. The company also provides pharmaceutical products, including Tiazac XC, Wellbutrin XL, Zovirax, Benzaclin, and Penlac; and Cold-FX, an OTC product in Canada, as well as Duromine/Metermine, Difflam, Duro-Tuss, and Rikodeine in Australia. In addition, it offers a range of treatments, including antibiotics, treatments for cardiovascular and neurological diseases, dermatological products, and diabetic therapies, as well as a range of various OTC products in Europe; and products for a range of therapeutic classes, including vitamin deficiency, antibacterials, and dermatology in Mexico and Brazil. Further, the company provides Duromine, Andolex, and Pholtex products in South Africa; and Difflam, Duro-Tuss, Tambocor, and Norgesic in Asia. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.
Is VRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.25
52 Week Low 8.31
Average Volume 13,239,883
200-Day Moving Average 13.4703
50-Day Moving Average 13.6607
20-Day Moving Average 13.6415
10-Day Moving Average 15.119
Average True Range 0.7256
ADX 34.12
+DI 41.99
-DI 14.85
Chandelier Exit (Long, 3 ATRs ) 14.7032
Chandelier Exit (Short, 3 ATRs ) 13.1168
Upper Bollinger Band 17.2056
Lower Bollinger Band 10.0774
Percent B (%b) 0.91
BandWidth 52.253784
MACD Line 0.7385
MACD Signal Line 0.4083
MACD Histogram 0.3303
Fundamentals Value
Market Cap 5.77 Billion
Num Shares 349 Million
EPS -3.27
Price-to-Earnings (P/E) Ratio -5.06
Price-to-Sales 0.44
Price-to-Book 1.03
PEG Ratio -0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.86
Resistance 3 (R3) 17.83 17.35 17.64
Resistance 2 (R2) 17.35 17.02 17.37 17.57
Resistance 1 (R1) 16.95 16.81 17.15 16.98 17.49
Pivot Point 16.47 16.47 16.58 16.49 16.47
Support 1 (S1) 16.07 16.14 16.27 16.10 15.59
Support 2 (S2) 15.59 15.93 15.61 15.51
Support 3 (S3) 15.19 15.59 15.44
Support 4 (S4) 15.22